CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 39 filers reported holding CUE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $97,971 | +444.3% | 33,900 | +2265.7% | 0.00% | – |
| Q1 2021 | $18,000 | -72.7% | 1,433 | -72.3% | 0.00% | – |
| Q4 2020 | $66,000 | +120.0% | 5,173 | +171.1% | 0.00% | – |
| Q3 2020 | $30,000 | -52.4% | 1,908 | -31.8% | 0.00% | – |
| Q2 2020 | $63,000 | +800.0% | 2,798 | +446.5% | 0.00% | – |
| Q1 2020 | $7,000 | -85.7% | 512 | -83.4% | 0.00% | – |
| Q4 2019 | $49,000 | +157.9% | 3,078 | +31.3% | 0.00% | – |
| Q3 2019 | $19,000 | -5.0% | 2,344 | +7.4% | 0.00% | – |
| Q2 2019 | $20,000 | +300.0% | 2,183 | +247.1% | 0.00% | – |
| Q1 2019 | $5,000 | +25.0% | 629 | -28.0% | 0.00% | – |
| Q4 2018 | $4,000 | +300.0% | 874 | +616.4% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 122 | -3.2% | 0.00% | – |
| Q2 2018 | $1,000 | – | 126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |